Dymedso

Dymedso Inc. is a Canadian medical technology company focused on developing and commercializing airway clearance devices for patients with respiratory conditions. The company was founded in 2000 by Yvon Robert and Louis Plante. The genesis of the company's core product, the Frequencer, came from co-founder Louis Plante, a cystic fibrosis (CF) patient who collaborated with a medical team from Sherbrooke University in Québec to create a new therapy device. This personal journey is central to the company's mission to provide less intrusive and more targeted physiotherapy options. Dymedso's primary market consists of hospitals, clinics, long-term care facilities, and rehabilitation centers. Revenue is generated through the direct sale of its medical devices, which retail for between US$15,000 and US$19,000, and through partnerships with government health departments.

The company's flagship product is the Frequencer®, a digitally controlled, electro-acoustical device that provides airway clearance therapy. It is indicated for patients with a range of respiratory ailments characterized by defective mucociliary clearance, such as cystic fibrosis, chronic bronchitis, bronchiectasis, asthma, and for post-operative care. The system consists of a control unit and a transducer, or "Power Head," that is placed externally on the patient's chest. Unlike traditional chest physiotherapy that relies on manual clapping or vest-based systems that use pressure and shaking, the Frequencer utilizes acoustic sound waves to induce vibrations in the chest wall. The device generates low-frequency sound waves, typically adjustable between 20 and 100 Hz, which are designed to match the resonance of the lungs. This acoustic energy helps to loosen and liquefy mucus secretions, making them easier for the patient to clear from their airways. The treatment is non-invasive, typically lasting around 20 minutes, and allows clinicians to monitor patient parameters like oxygen saturation in real-time. The Frequencer has received regulatory clearance from Health Canada, the U.S. FDA, and holds a CE mark for use in Europe.

Keywords: airway clearance, respiratory therapy, medical device, cystic fibrosis treatment, acoustic wave therapy, bronchial drainage, Frequencer, pulmonary physiotherapy, mucus clearance, chest physiotherapy, respiratory ailments, neuromuscular disorders, post-operative atelectasis, non-invasive treatment, chronic bronchitis, bronchiectasis, asthma therapy, mucociliary clearance, electro-acoustical transducer, lung resonance